BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 12803217)

  • 1. Aspirin and the prevention of colorectal cancer.
    Berman KS
    N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin use and potential mechanisms for colorectal cancer prevention.
    Williams CS; Smalley W; DuBois RN
    J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 4. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of colorectal cancer by aspirin use.
    Giovannucci E
    Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 8. NSAIDs to prevent colorectal cancer: a question of sensitivity.
    Elder DJ; Paraskeva C
    Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin and colon cancer--targeting prevention?
    Markowitz SD
    N Engl J Med; 2007 May; 356(21):2195-8. PubMed ID: 17522404
    [No Abstract]   [Full Text] [Related]  

  • 10. Rational use of analgesic and antiinflammatory drugs.
    Crofford LJ
    N Engl J Med; 2001 Dec; 345(25):1844-6. PubMed ID: 11752364
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
    Kleibeuker JH; de Vries EG
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coxibs, selective inhibitors of cyclooxygenase-2.
    Rich SA
    N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
    [No Abstract]   [Full Text] [Related]  

  • 14. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 15. A magic bullet for mucosal protection...and aspirin is the trigger!
    Wallace JL; Fiorucci S
    Trends Pharmacol Sci; 2003 Jul; 24(7):323-6. PubMed ID: 12871661
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.
    Hawk ET; Viner JL; Umar A
    Prog Exp Tumor Res; 2003; 37():210-42. PubMed ID: 12795057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylaxis of colorectal cancer with non steroidal anti-inflammatory drugs- a new reality?].
    Cijevschi C; Rezmireş A; Mintescu E; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):35-40. PubMed ID: 12635357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
    Steinhilber D
    Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.